Accro Bioscience Announces First Patient Enrolled in Phase II/III Clinical Trial of Highly Selective TYK2/JAK1 Inhibitor AC-201 for Non-Segmental Vitiligo

NEW YORK and SUZHOU, China, Nov. 11, 2026 /PRNewswire/ — Accro Bioscience…

Xinhua Silk Road: Smart tech drives modern agriculture development in Zaozhuang, Shandong

BEIJING, Nov. 11, 2026 /PRNewswire/ — At the Zhongken Modern Agriculture Demonstration Park in…

Modaxo Returns as Platinum Partner for UITP Summit Hamburg 2027, Reinforcing Long-Term Commitment to Public Transport

ebblo, a Modaxo company, joins as Gold Partner TORONTO, Nov. 11, 2026…

Novo Tellus statement regarding ISDN Holdings

SINGAPORE, Nov. 11, 2026 /PRNewswire/ — Novo Tellus has received enquiries following our…

Ali Y. Koç: 'The Energy Transition Has Become the Cornerstone of Competitiveness in Industry'

At COP31’s Highly Sensational Panel, the Impact of Climate Policies on Global…

Ascletis Submits IND Application to the U.S. FDA for ASC30_39 FDC, a Potentially First-in-Class Oral Small Molecule Fixed-Dose Combination of GLP-1R Agonist and Selective Amylin Receptor Agonist, for the Treatment of Obesity

–  ASC30_39 FDC, a once-daily oral fixed-dose combination (FDC) tablet of small…

Binance Blockchain Week Bangkok 2026 Unveils First Wave of Speakers, Spotlighting the Convergence of Traditional Finance and Digital Assets

The flagship event, under this year’s theme of ‘Evolve’, will convene leading…

Xinhua Silk Road: Jing'an District promotes investment opportunities, global business cooperation at 2026 CIIE

BEIJING, Nov. 11, 2026 /PRNewswire/ — Jing’an District of Shanghai held a…